Birdwatch Note Rating
2023-11-25 02:00:39 UTC - HELPFUL
Rated by Participant: B6740066CF77920D2C877855DDA1E3AA81E1EEDFD76ED4F0978934B79AB9F67A
Participant Details
Original Note:
Claim is false. In the trial the effectiveness of the vaccine for severe RSV in babies was 81.8%. The clinical trial efficacy & safety data is publicly available. The available data are insufficient to establish a causal relationship between preterm birth & the vaccine https://www.fda.gov/news-events/press-announcements/fda-approves-first-vaccine-pregnant-individuals-prevent-rsv-infants https://www.nejm.org/doi/10.1056/NEJMoa2216480 https://www.fda.gov/media/169361/download
All Note Details